Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2025-05-07 AGM Information
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
FR Minutes AGM 24.04.25 WEBSITE.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROCÈS-VERBAL DE L'ASSEMBLÉE GÉNÉRALE ANNUELLE DES ACTIONNAIRES TENUE AU SIÈGE SOCIAL LE JEUDI 24 AVRIL 2025" (Minutes of the Annual General Meeting of Shareholders held at the registered office on Thursday, April 24, 2025). The content details the constitution of the meeting bureau, verification of quorum, and lists resolutions voted upon, such as the approval of annual accounts, remuneration reports, and director appointments. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2025-05-07 French
NL Minutes AGM 24.04.25 WEBSITE.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "NOTULEN" (Minutes) of the "GEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Ordinary General Meeting of Shareholders) held on April 24, 2025. The content details the composition of the meeting bureau, verification of attendees, the agenda (which includes approval of the 2024 annual accounts, remuneration report, and appointment/re-election of directors), and the proposed resolutions. This structure and content are characteristic of the official minutes recorded during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information/Minutes).
2025-05-07 Dutch
250404 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement regarding the company's share repurchase program, specifically detailing the number of shares repurchased, the dates of the transactions, and the average prices paid. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-04-04 English
250404 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from UCB SA regarding the execution and closure of a share buyback program ('Rachat d'actions propres'). It details the number of shares repurchased, the dates, and the average prices paid. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-04-04 French
250404 - Verwerving van eigen aandelen_NL.pdf
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from UCB NV regarding the completion of its 2025 share buyback program. It details the number of shares repurchased, the dates of the transactions, and the average prices paid. This falls directly under the category of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares.
2025-04-04 Dutch
250328 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is a formal disclosure by UCB SA/NV regarding the repurchase of its own shares on Euronext Brussels. It provides specific details on the number of shares repurchased, the dates of the transactions, and the price ranges paid. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-03-28 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.